Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo …

RH Weisler, SA Montgomery, WR Earley… - International clinical …, 2012 - journals.lww.com
Prospectively planned pooled analysis evaluating the efficacy of quetiapine extended
release (XR) monotherapy in major depressive disorder (MDD). Data were pooled from two …

A randomized study on comparing effect and safety of wuling capsule and deanxit in patients with anxiety or depression status

L Shi, X Zhao, Y Wang, J Zhang… - Chinese Journal of …, 2009 - pesquisa.bvsalud.org
Objective To evaluate the efficacy and safety of wuling capsule compared with deanxit in
treatment of patients with depression or anxiety status. Methods A total of 139 patients with …

A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major …

M Bauer, N El-Khalili, C Datto, J Szamosi… - Journal of affective …, 2010 - Elsevier
BACKGROUND: Two positive studies evaluated adjunctive extended release quetiapine
fumarate (quetiapine XR) in patients with major depressive disorder (MDD) showing …

MAOIs: issues in treatment adherence and rates of treatment failure

LJ Cohen, DA Sclar - The Journal of Clinical Psychiatry, 2013 - psychiatrist.com
Treatment guidelines recommend initiating newer antidepressants as first-line therapy for
patients with depression, but response and remission rates remain low and multiple …

[HTML][HTML] A randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major …

G Wang, A McIntyre, WR Earley, S Raines… - Psychopharmacology …, 2012 - ncbi.nlm.nih.gov
Objectives Evaluate the efficacy and tolerability of once-daily extended release quetiapine
fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD) …

Open-label placebo for major depressive disorder: a pilot randomized controlled trial

JM Kelley, TJ Kaptchuk, C Cusin, S Lipkin… - Psychotherapy and …, 2012 - karger.com
In randomized controlled trials (RCTs), major depressive disorder (MDD) patients treated
with double-blind placebos often show substantial improvement. Indeed, two meta-analyses …

A double-blind, placebo-controlled study with acute and continuation phase of quetiapine and lithium in adults with bipolar depression (EmboldenI)

AH Young, A Carlsson, B Olausson… - Bipolar …, 2008 - search.ebscohost.com
Abstract In Volume 10, Supplement 1, February 2008, this Abstract was omitted from the
Poster Session. The correct citation for the Abstract is Bipolar Disord 2008; 10 (Suppl. 1). We …

Analysis of Pooled Data: Once-daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients with Major Depressive Disorder (MDD)

S Montgomery, R Weisler, W Earley, M Åstrom… - European …, 2009 - cambridge.org
Aim: To evaluate efficacy and tolerability of quetiapine XR monotherapy in patients with
MDD. Methods: Data were analysed from two 6-week, multicentre, double-blind, placebo …

Effect of Lumateperone (ITI-007) on Quality of Life and Functional Disability in the Treatment of Bipolar Depression

JB Edwards, S Durgam, SG Kozauer, R Jain… - CNS …, 2023 - search.proquest.com
Methods Patients (18–75 years) with bipolar I or bipolar II disorder experiencing a major
depressive episode (Montgomery-Åsberg Depression Rating Scale [MADRS] Total score≥ …

Meta-analysis of randomized controlled trials to assess the effectiveness and safety of free and easy wanderer plus, a polyherbal preparation for depressive disorders

F Qin, XA Wu, Y Tang, Q Huang, ZJ Zhang… - Journal of psychiatric …, 2011 - Elsevier
Free and Easy Wanderer Plus (FEWP) is a polyherbal preparation which therapeutic
benefits have been extensively evaluated in patients with various depressive disorders. The …